Importance Type 2 diabetes (T2D) is associated with an increased risk of kidney stones.
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) might lower the risk of nephrolithiasis …

Oxalate is a metabolic end-product whose systemic concentrations are highly variable
among individuals. Genetic (primary hyperoxaluria) and non-genetic (eg, diet, microbiota …

Congestive heart failure produces fluid volume overload, central and renal venous pressure
elevation, and consequently renal congestion, which results in worsening renal function …

Calcium oxalate (CaOx) nephrolithiasis is a prevalent disorder linked to metabolism.
Examining metabolic alterations could potentially give an initial understanding of the origins …

Results The current cross-sectional study used the Japanese administrative database
maintained by MDV analyzer (Medical Data Vision Co., Ltd., Tokyo, Japan), a web tool …

Renal congestion is an issue of cardiorenal syndrome in patients with heart failure. Recent
clinical and basic studies suggest a renoprotective potential of sodium–glucose …

Background The present study aimed to explore the quantitative effects of sodium-glucose
cotransporter-2 (SGLT-2) inhibitors on liver functions in patients with nonalcoholic fatty liver …

Abstract Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic
drugs. Guidelines for the proper use of SGLT2 inhibitors recommend caution regarding …

Background Dietary sugar intake is gradually considered a risk factor for many diseases. A
sugary diet was positively associated with risk of nephrolithiasis, but the specific …

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail
diabetic elders with chronic kidney disease Effects of SGLT2 inhibition via empagliflozin on …